Biography Berend van Meer
Chief Technology Officer Demcon biovitronix
Berend van Meer studied Electrical Engineering at Delft University of Technology. In 2020, he obtained his PhD cum laude at the Leiden University Medical Center. His thesis covered the measuring and quantifying the effect of drugs and diseases on heart muscle cells grown from human stem cells.
He received the Hugo van Poelgeest Prize for his research into alternatives to animal testing. In addition, he was granted the EIT Health PhD Transition Fellowship to bring his PhD research to application.
He is driven by the combination of engineering and biology, specifically for the development and application of organs-on-chip systems. Berend co-founded the Organ-on-Chip Center in Twente in 2019. From 2021 to 2022 he was a board member of the Institute for human organ and Disease Model Technologies (hDMT) and one of the designers of the domain 'Biomedical Production Technology' within the National Growth Fund program NXTGEN HIGHTECH. As of February 2022, Berend is co-founder and Chief Technology Officer of Demcon Biovitronix, which aims to bring organs-on-chip and microphysiological systems to the market and application.